首页> Haematologica> Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.

导出 OA

翻译打印收藏纠错

第一作者： Lars P,Jordheim

第一单位： Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France Hospices Civils de Lyon, France ProfileXpert, Lyon, France lars-petter.jordheim@univ-lyon1.fr.

作者： Lars P,Jordheim ^[1] ; Vincent,Ribrag ^[2] ; Hervé,Ghesquieres ^[3] ; Sophie,Pallardy ^[4] ; Richard,Delarue ^[5] ; Hervé,Tilly ^[6] ; Corinne,Haioun ^[7] ; Fabrice,Jardin ^[8] ; Delphine,Demangel ^[9] ; Gilles A,Salles ^[10] ; Charles,Dumontet ^[11]

作者单位： Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France Hospices Civils de Lyon, France ProfileXpert, Lyon, France lars-petter.jordheim@univ-lyon1.fr. ^[1] Institut Gustave Roussy, Villejuif, France. ^[2] Hematology, Centre Léon Bérard, UMR 5239 CNRS, Lyon, France. ^[3] GELA-RC, Hospices Civils de Lyon, Pierre Bénite, France. ^[4] Hematology, Necker Hospital, Paris, France. ^[5] Centre Henri Becquerel, Rouen, France. ^[6] Hematology, Hôpital Henri Mondor, Créteil, France. ^[7] Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France. ^[8] Hospices Civils de Lyon, France ProfileXpert, Lyon, France. ^[9] Hospices Civils de Lyon, Centre Hospitalier Universitaire Lyon-Sud, Hématologie, Université Lyon 1, UMR 5239 CNRS, France. ^[10] Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France Hospices Civils de Lyon, France ProfileXpert, Lyon, France Laboratory of Hematology, Hospices Civils de Lyon, Pierre-Bénite, France. ^[11]

关键词 ABCB1 CBR1 R-CHOP SNP non-Hodgkin lymphoma toxicity